NCT06174272 Transitional Care Program for Fluid Overload in Cirrhosis
| NCT ID | NCT06174272 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Milton S. Hershey Medical Center |
| Condition | Cirrhosis, Liver |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-02-15 |
| Primary Completion | 2027-02-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-02-15 with a primary completion date of 2027-02-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn about an intensive monitoring plan (transitional care program) in patients with cirrhosis and excessive swelling that are going to be discharged from the hospital. The main question\[s\] it aims to answer are: * How much time and what resources are needed to run such a program * How well do patients follow up with the phone calls, bloodwork, and doctor appointments? * Do the patients enrolled in the program have less need for hospitalization later, less kidney injury, better fluid control, and/or better survival compared to patients that are not in the program? Participants will * Be given a digital scale and a binder with educational material and a log to monitor their weights after discharge from the hospital * Receive a phone call from the study team within 72 hours of discharge and weekly * Be given a follow up appointment with hepatology within 4 weeks of discharge Researchers will compare participants in this program to patients that receive normal care to see if there are differences in need for hospitalization later, kidney injury, fluid control, and/or survival.
Eligibility Criteria
Inclusion Criteria: * Patients \> 18 years of age. * Inpatient at Penn State Health, Milton S. Hershey Medical Center. * Diagnosis of cirrhosis. * Hospitalized with fluid overload (ascites and/or significant anasarca/edema) requiring diuretic therapy. * English speaking Exclusion Criteria: * Placement of a TIPS. * Ascites from an etiology other than cirrhosis, such as malignancy, heart failure, pancreatitis, nephrotic syndrome. * Non-English speaking
Contact & Investigator
Karen L Krok, MD
PRINCIPAL INVESTIGATOR
Penn State College of Medicine
Frequently Asked Questions
Who can join the NCT06174272 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cirrhosis, Liver. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06174272 currently recruiting?
Yes, NCT06174272 is actively recruiting participants. Contact the research team at kkrok@pennstatehealth.psu.edu for enrollment information.
Where is the NCT06174272 trial being conducted?
This trial is being conducted at Hershey, United States.
Who is sponsoring the NCT06174272 clinical trial?
NCT06174272 is sponsored by Milton S. Hershey Medical Center. The principal investigator is Karen L Krok, MD at Penn State College of Medicine. The trial plans to enroll 20 participants.